On the occasion of Sidaction 2019, the Laboratory of Pharmacology and Applied Biology (LBPA - CNRS, ENS Paris-Saclay), organizes on March 28, 2019 in partnership with the École normale supérieure Paris-Saclay and the support of the Université Paris-Saclay, the 3rd edition of the "Research at the Service of Prevention" (RSP day). A day dedicated to the fight against AIDS.
It is a day of meetings and exchanges around the theme HIV / AIDS led by experts recognized in their field to take stock of research currently conducted on HIV, whether it is basic research, clinics, Societal or Preventive.
For this 3rd edition, Mrs Françoise BARRE-SINOUSSI, Nobel Prize for Medicine 2008, co-discoverer of the AIDS virus and President of the association Sidaction, will speak on the theme: "HIV / AIDS, the challenges of the 21st century"
To inquire is to protect !
In 2017, HIV is 1 infection every 17 seconds, or 5000 new infections per day. Around the world, nearly 37 million people are living with HIV, 59% of whom are on antiretroviral treatment, 18 million people have been newly infected and 1 in 4 HIV-positive people are unaware that they have the virus. In France there were 6,000 new infections of which 14% were under 25 years old and 22% were over 50 years old.
AIDS is perceived today as a "chronic pathology", it has gone from the status of "threat" to "acceptable risk". This results in the decline of preventive behaviors, and consequently a difficult control of the epidemic. Prevention remains today the most effective way to fight against this pandemic.
This event is free and open to all on registration required. It is an opportunity to meet the actors involved in the fight against AIDS and discover their work, but also to raise funds for the benefit of the association Sidaction.
We give you an appointment on Thursday, March 28, 2019
at the École normale supérieure Paris-Saclay (in Cachan) to find out more!
HIV research at LBPA
Researchers commit themselves every day in the fight against AIDS to understand the functioning of the virus, find treatments, vaccines, means of prevention effective ... This is the case of LBPA!
Indeed, since 1987, the "retrovirus theme" is omnipresent in the laboratory, initially introduced by its Director, Professor Claude PAOLETTI to study three essential steps in the retroviral cycle: penetration, reverse transcription and integration. It was more focused on the study of integrase in the 90s under the direction of Professor Christian AUCLAIR. Then the laboratory then specialized in the pharmacological study of anti-integrase compounds including the development of in vitro integration tests with the arrival of Dr. Jean-François MOUSCADET.
Today, research on HIV-1 continues with, among others, Dr. Olivier DELELIS, Research Director at the CNRS, and Dr. Clémence RICHETTA, Associate Professor at ENS Paris-Saclay who work on problematic of resistance to anti-integrase; Dr. Philippe FOSSE and Olivier MAUFFRET, Research Directors at the CNRS who are studying the nucleo-capsid protein of HIV-1 (NCp7).